Synchronous Disease Kinetics in a Murine Model for Enterohemorrhagic E-coil Infection Using Food-Borne Inoculation
Synchronous Disease Kinetics in a Murine Model for Enterohemorrhagic E-coil Infection Using Food-Borne Inoculation
复制标题
DOI:
10.3389/fcimb.2016.00138
复制
发表时间:
2016-11-03
影响因子:
5.7
通讯作者:
Leong, John M.
中科院分区:
文献类型:
--
作者:
Flowers, Laurice J.;Ghanem, Elsa N. Bou;Leong, John M.
Upon colonization of the intestinal epithelium, the attaching and effacing (AE) pathogen Enterohemorrhagic Escherichia coil (EHEC) effaces microvilli and forms pedestal-like structures beneath the adherent bacterium. The production of one of its virulence factors, the phage-encoded Shiga toxin (Stx) results in systemic disease, including the development of renal failure. Although EHEC does not productively infect conventional mice, EHEC infection can be modeled in mice utilizing a derivative of the natural murine AE pathogen Citrobacter rodentium (CR). Gavage of mice with CR(Phi Stx(2dact)), a C. rodentiurn lysogenized by a phage encoding an Stx variant with high potency in mice, features AE lesion formation on intestinal epithelium and Stx-mediated systemic disease, including renal damage. This model is somewhat limited by mouse-to-mouse variation in the course of disease, with the time to severe morbidity (and required euthanasia) varying by as many as 5 days, a feature that limits pathological analysis at defined stages of disease. In the current study, we altered and optimized the preparation, dose, and mode of delivery of CR(Phi Stx(2dact)), using food-borne route of infection to generate highly synchronous disease model. We found that food borne inoculation of as few as 3 x 10(4) CR(Phi Stx(2dact)) resulted in productive colonization and severe systemic disease. Upon inoculation of 1 x 10(8) bacteria, the majority of infected animals suffered weight loss beginning 5 days post-infection and all required euthanasia on day 6 or 7. This enhanced murine model for EHEC infection should facilitate characterization of the pathology associated with specific phases of Stx-mediated disease.